89bio Clinical Study Site

Concord, North Carolina 28027

0 studies enrolling now · 2 studies all time

What they study most

NASH, NASH - Nonalcoholic Steatohepatitis

Studies at this site

• Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH) — Completed
• A Multiple Ascending Dose Study of Pegozafermin in Participants With Biopsy Confirmed Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) and at High Risk of NASH — Completed